Welcome

Sign out Have a question? We're here to help

Sign out

Madrigal Pharmaceuticals Inc (MDGL)

$67.19 0.99 (1.50%)

19:40 EDT MDGL Stock Quote Delayed 20 Minutes

Volume:

Previous Close $67.19

Market Cap 957.51M

PE Ratio -26.98

EPS -2.49

Volume (Avg. Vol.) 282,184

Day's Range 65.62 - 70.15

52-Week Range 56.82 - 145.16

Dividend & Yield N/A (N/A)

MDGL Stock Predictions, Articles, and Madrigal Pharmaceuticals Inc News

From InvestorPlace
From the Web

5 Biotech Stocks to Play the Sector’s Next Big Trend: NASH

By Aaron Levitt, InvestorPlace Contributor Sep 26, 2018

Looking for blockbuster potential? These five biotech stocks may have found it in treating NASH -- an untapped market of up to $35 billion.

4 Biotech Stocks With Leaky Pipelines

By Regina Borsellino Apr 10, 2018

A strong pipeline can make or break biotech stocks, ensuring strong profits for years to come. These four biotech companies don't make the cut.

We’re Not Very Worried About Madrigal Pharmaceuticals’s (NASDAQ:MDGL) Cash Burn Rate

From Simply Wall St Apr 7, 2020

Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdgl/madrigal-pharmaceuticals/news/were-not-very-worried-about-madrigal-pharmaceuticalss-nasdaqmdgl-cash-burn-rate/">Read More...</a></div>

The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO

From Benzinga Apr 3, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2) BELLUS Health Inc (NASDAQ:...

Oversold Conditions For Madrigal Pharmaceuticals (MDGL)

From Market News Video Apr 1, 2020

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection

From Benzinga Mar 19, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ...

The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates

From Benzinga Mar 18, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) BioNTech SE – ADR...

Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (NASDAQ: MDGL) and BELLUS Health (NASDAQ: BLU)

From Analyst Ratings Mar 18, 2020

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Madrigal Pharmaceuticals (MDGL – Research Report) and BELLUS Health (BLU – Research Report) with bullish sentiments. Madrigal Pharmaceuticals (MDGL) In a report released yesterday, Jay Olson from Oppenheimer maintained a Buy rating on Madrigal Pharmaceuticals. The company’s

Navellier Ratings

Total Grade

Sell

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Welcome

Breaking news

Madrigal Pharmaceuticals Inc (MDGL)

Navellier Ratings

Total Grade

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Already a subscriber?

Welcome

Breaking news

Madrigal Pharmaceuticals Inc (MDGL)

MDGL Stock Predictions, Articles, and Madrigal Pharmaceuticals Inc News

Navellier Ratings

Total Grade

Subscriber Sign in